Therapeutic strategies for SLE involving cytokines: Mechanism-oriented therapies especially IFN-λ targeting gene therapy

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Hayashi, Toshiharu ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABETIMUS; ADENOVIRUS VECTOR; ALPHA INTERFERON; BETA INTERFERON; CD40 LIGAND MONOCLONAL ANTIBODY; CORTICOSTEROID; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EDRATIDE; GAMMA INTERFERON; IMMUNOLOGIC AGENT; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BH7; OLIGONUCLEOTIDE; PEPTIDE; PLASMID DNA; PROTEIN TBETA EXR; TOLEROGENIC PEPTIDE; TRANSFORMING GROWTH FACTOR BETA1; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VACCINIA VACCINE;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL POPULATION; DENDRITIC CELL; DRUG MECHANISM; GENE TARGETING; GENE THERAPY; HUMAN; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL; VIRUS RECOMBINANT;

ANIMALS; CYTOKINES; DENDRITIC CELLS; GENE THERAPY; HUMANS; INTERFERON-GAMMA; LUPUS ERYTHEMATOSUS, SYSTEMIC; TH1 CELLS;

EID: 77956844800     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/461641     Document Type: Review

References (147)

1. Klinman D. M., Steinberg A. D., Inquiry into murine and human lupus Immunological Reviews 1995 144 157 193
2. Koffler D., Immunopathogenesis of systemic lupus erythematosus Annual Review of Medicine 1974 25 149 164
3. Doria A., Briani C., Lupus: improving long-term prognosis Lupus 2008 17 3 166 170
4. Van Raalte D. H., Ouwens D. M., Diamant M., Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? European Journal of Clinical Investigation 2009 39 2 81 93
5. Monneaux F., Muller S., Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects Arthritis Research Therapy 2009 11 3, article 234
6. Amoura Z., Haroche J., Piette J.-C., Systemic lupus erythematosus: future therapeutic avenues Revue de Medecine Interne 2008 29 9 718 724
7. Sthoeger Z. M., Sharabi A., Molad Y., Asher I., Zinger H., Dayan M., Mozes E., Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): immunomodulation of gene expression Journal of Autoimmunity 2009 33 1 77 82
8. Llorente L., Richaud-Patin Y., Garca-Padilla C., Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus Arthritis Rheumatism 2000 43 1790 1800
9. Mathian A., Weinberg A., Gallegos M., Banchereau J., Koutouzov S., IFN- induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White)F1 but not in BALB/c mice Journal of Immunology 2005 174 5 2499 2506
10. Crow M. K., Kirou K. A., Interferon- in systemic lupus erythematosus Current Opinion in Rheumatology 2004 16 5 541 547
11. Finck B. K., Chan B., Wofsy D., Interleukin 6 promotes murine lupus in NZB/NZW F 1 mice Journal of Clinical Investigation 1994 94 2 585 591
12. Prud'homme G. J., Lawson B. R., Theofilopoulos A. N., Anticytokine gene therapy of autoimmune diseases Expert Opinion on Biological Therapy 2001 1 3 359 373
13. Kunz M., Ibrahim S. M., Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity Mediators of Inflammation 2009 2009
14. Wong C. K., Lit L. C. W., Tam L. S., Li E. K. M., Wong P. T. Y., Lam C. W. K., Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity Clinical Immunology 2008 127 3 385 393
15. Steinmetz O. M., Turner J. E., Paust H. J., Lindner M., Peters A., Heiss K., Velden J., Hopfer H., Fehr S., Krieger T., Meyer-Schwesinger C., Meyer T. N., Helmchen U., Mittrcker H. W., Stahl R. A., Panzer U., CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis Journal of Immunology 2009 183 7 4693 4704
16. Daz-Jouanen E., Abud-Mendoza C., Garza-Elizondo M. A., Grupo de Estudio de Nuevas Terapias de Enfermedades reumticas (GENTE) Revista de Investigacin Clnica 2009 61 252 266
17. Alarcn-Segovia D., Tumlin J. A., Furie R. A., McKay J. D., Cardiel M. H., Strand V., Bagin R. G., Linnik M. D., Hepburn B., Aelion J., Appel G. B., Aranow C., Ballou S., Becker M., Becker N. J., Belmont H. M., Buyon J. P., Bohan A., Brelsford W. G., Carteron N. L., Cronin M. E., DeHoratius R. J., Espinoza L. R., Genovese M. C., Gilkeson G., Gil-Aguado A., Gluck O., Granda J. L., Hill M., Howard P., Ingelmo M., Kalunian K. C., Kammer G. M., Kanik K., Kaplan S., Kenney H. M., Kurtzman N. A., Lahita R. G., Liebling M. R., Lindberg J. S., Manzi S., Merrill J. T., Moreland L. W., Neuwelt C. M., Petri M. A., Ramsey-Goldman R., Rosenblatt S. G., Rothfield N., Schousboe J. T., Sewell K. L., Sherrer Y., Smith D. B., Spinowitz B. S., Staub R. M., Stern S., Stevenson J. T., Van Vollenhoven R., Varga J., Vilardell-Tarres M., Wallace D. J., LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study Arthritis and Rheumatism 2003 48 2 442 454
18. Kalunian K. C., Davis JC. Jr., Merrill J. T., Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial Arthritis Rheumatism 2002 46 3251 3258
19. Yao Y., Richman L., Higgs B. W., Morehouse C. A., De Los Reyes M., Brohawn P., Zhang J., White B., Coyle A. J., Kiener P. A., Jallal B., Neutralization of interferon- / -inducible genes and downstream effect in a phase I trial of an anti-interferon- monoclonal antibody in systemic lupus erythematosus Arthritis and Rheumatism 2009 60 6 1785 1796
20. Mohrs M., Ledermann B., Khler G., Dorfmller A., Gessner A., Brombacher F., Differences between IL-4- and IL-4 receptor -deficient mice in chronic Leishmaniasis reveal a protective role for IL-13 receptor signaling Journal of Immunology 1999 162 12 7302 7308
21. Criscione L. G., Pisetsky D. S., B lymphocytes and systemic lupus erythematosus Current Rheumatology Reports 2003 5 4 264 269
22. Horwitz D. A., Zheng S. G., Wang J., Gray J. D., Critical role of IL-2 and TGF- in generation, function and stabilization of Foxp3+ CD4+ Treg European Journal of Immunology 2008 38 4 912 915
23. Mitsias D. I., Kapsogeorgou E. K., Moutsopoulos H. M., Sjgren's syndrome: why autoimmune epithelitis? Oral Diseases 2006 12 6 523 532
24. Hayashi T., Hasegawa K., Ichinohe N., ICAM-1 expression on endothelium and systemic cytokine production in cutaneous neutrophilic leukocytoclastic vasculitis in NZBxNZWF 1 mice Histology and Histopathology 2005 20 1 45 52
25. Hayashi T., Hayashi H., Fujii T., Adachi C., Hasegawa K., Ultrastructure of myoepithelial cells as a target cell in sialoadenitis of submandibular glands of lupus-prone female NZBxNZWF 1 mice Virchows Archiv 2008 453 2 177 188
26. Banchereau J., Pascual V., Type I interferon in systemic lupus erythematosus and other autoimmune diseases Immunity 2006 25 3 383 392
27. Kang H.-K., Liu M., Datta S. K., Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells Journal of Immunology 2007 178 12 7849 7858
28. Mosmann T. R., Coffman R. L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties Annual Review of Immunology 1989 7 145 173
29. Theofilopoulos A. N., Koundouris S., Kono D. H., Lawson B. R., The role of IFN- in systemic erythematosus: a challenge tothe Th1/Th2 paradigm in autoimmunity Arthritis Research 2001 3 3 136 141
30. Turner J. E., Steinmetz O. M., Stahl R. A., Panzer U., Targeting of Th1-associated chemokine receptors CXCR3 and CCR5 as therapeutic strategy for inflammatory diseases Mini-Reviews in Medicinal Chemistry 2007 7 11 1089 1096
31. Hooks J. J., Moutsopoulos H. M., Geis S. A., Stahl N. I., Decker J. L., Notkins A. L., Immune interferon in the circulation of patients with autoimmune disease New England Journal of Medicine 1979 301 1 5 8
32. Ishida H., Muchamuel T., Sakaguchi S., Andrade S., Menon S., Howard M., Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice Journal of Experimental Medicine 1994 179 1 305 310
33. Kaneko Y., Hirose S., Abe M., Yagita H., Okumura K., Shirai T., CD40-mediated stimulation of B1 and B2 cells: implication in autoantibody production in murine lupus European Journal of Immunology 1996 26 12 3061 3065
34. Nakajima A., Hirose S., Yagita H., Okumura K., Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice Journal of Immunology 1997 158 3 1466 1472
35. Peng S. L., Moslehi J., Craft J., Roles of interferon- and interleukin-4 in murine lupus Journal of Clinical Investigation 1997 99 8 1936 1946
36. Haas C., Ryffel B., Le Hir M., IFN- receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice Journal of Immunology 1998 160 8 3713 3718
37. Pollard K. M., Hultman P., Kono D. H., Using single-gene deletions to identify checkpoints in the progression of systemic autoimmunity Annals of the New York Academy of Sciences 2003 987 236 239
38. Richards H. B., Satoh M., Jennette J. C., Croker B. P., Yoshida H., Reeves W. H., Interferon- is required for lupus nephritis in mice treated with the hydrocarbon oil pristane Kidney International 2001 60 6 2173 2180
39. Smith-Bouvier D. L., Divekar A. A., Sasidhar M., Du S., Tiwari-Woodruff S. K., King J. K., Arnold A. P., Singh R. R., Voskuhl R. R., A role for sex chromosome complement in the female bias in autoimmune disease Journal of Experimental Medicine 2008 205 5 1099 1108
40. Sugiyama M., Funauchi M., Yamagata T., Nozaki Y., Yoo B. S., Ikoma S., Kinoshita K., Kanamaru A., Predominant inhibition of Th1 cytokines in New Zealand black/white F 1 mice treated with FK506 Scandinavian Journal of Rheumatology 2004 33 2 108 114
41. Takahashi S., Fossati L., Iwamoto M., Merino R., Motta R., Kobayakawa T., Izui S., Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice Journal of Clinical Investigation 1996 97 7 1597 1604
42. Tokano Y., Morimoto S., Kaneko H., Amano H., Nozawa K., Takasaki Y., Hashimoto H., Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)relation to Th1- and Th2-derived cytokines Clinical and Experimental Immunology 1999 116 1 169 173
43. Tucci M., Lombardi L., Richards H. B., Dammacco F., Silvestris F., Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis Clinical and Experimental Immunology 2008 154 2 247 254
44. Calvani N., Richards H. B., Tucci M., Pannarale G., Silvestris F., Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis Clinical and Experimental Immunology 2004 138 1 171 178
45. Favilli F., Anzilotti C., Martinelli L., Quattroni P., De Martino S., Pratesi F., Neumann D., Beermann S., Novick D., Dinarello C. A., Boraschi D., Migliorini P., IL-18 activity in systemic lupus erythematosus Annals of the New York Academy of Sciences 2009 1173 301 309
46. Rus V., Atamas S. P., Shustova V., Luzina I. G., Selaru F., Magder L. S., Via C. S., Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array Clinical Immunology 2002 102 3 283 290
47. Hasegawa K., Hayashi T., Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB NZWF 1 mice Lupus 2003 12 11 838 845
48. Shimizu S., Sugiyama N., Masutani K., Sadanaga A., Miyazaki Y., Inoue Y., Akahoshi M., Katafuchi R., Hirakata H., Harada M., Hamano S., Nakashima H., Yoshida H., Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1) Journal of Immunology 2005 175 11 7185 7192
49. Singh R. R., Saxena V., Zang S., Li L., Finkelman F. D., Witte D. P., Jacob C. O., Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis Journal of Immunology 2003 170 9 4818 4825
50. Paul W. E., Seder R. A., Lymphocyte responses and cytokines Cell 1994 76 2 241 251
51. Borel Y., Lewis R. M., Andre-Schwartz J., Stollar B. D., Diener E., Treatment of lupus nephritis in adult (NZB + NZW)F 1 mice by cortisone-facilitated tolerance to nucleic acid antigens Journal of Clinical Investigation 1978 61 2 276 286
52. Gursel I., Gursel M., Yamada H., Ishii K. J., Takeshita F., Klinman D. M., Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation Journal of Immunology 2003 171 3 1393 1400
53. Dong L., Ito S., Ishii K. J., Klinman D. M., Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice Arthritis and Rheumatism 2005 52 2 651 658
54. Zeuner R. A., Verthelyi D., Gursel M., Ishii K. J., Klinman D. M., Influence of stimulatory and suppressive DNA motifs on host susceptibility to inflammatory arthritis Arthritis and Rheumatism 2003 48 6 1701 1707
55. Sano K., Shirota H., Terui T., Hattori T., Tamura G., Oligodeoxynucleotides without CpG motifs work as adjuvant for the induction of Th2 differentiation in a sequence-independent manner Journal of Immunology 2003 170 5 2367 2373
56. Shirota H., Gursel M., Klinman D. M., Suppressive oligodeoxynucleotides inhibit Th1 differentiation by blocking IFN- -and IL-12-mediated signaling Journal of Immunology 2004 173 8 5002 5007
57. Dong L., Ito S.-I., Ishii K. J., Klinman D. M., Suppressive oligonucleotides protect against collagen-induced arthritis in mice Arthritis and Rheumatism 2004 50 5 1686 1689
58. Hayashi T., Yasutomi Y., Hasegawa K., Sasaki Y., Onodera T., Interleukin-4-expressing plasmid DNA inhibits reovirus type-2-triggered autoimmune insulitis in DBA/1 J suckling mice International Journal of Experimental Pathology 2003 84 2 101 106
59. Tominaga Y., Nagata M., Yasuda H., Okamoto N., Arisawa K., Moriyama H., Miki M., Yokono K., Kasuga M., Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice Clinical Immunology and Immunopathology 1998 86 2 209 218
60. Conlon P. J., Tyler S., Grabstein K. H., Morrissey P., Interleukin-4 (B-cell stimulatory factor-1) augments the in vivo generation of cytotoxic cells in immunosuppressed animals Biotechnology Therapeutics 1989 1 1 31 41
61. Sloane E. M., Soderquist R. G., Maier S. F., Mahoney M. J., Watkins L. R., Milligan E. D., Long-term control of neuropathic pain in a non-viral gene therapy paradigm Gene Therapy 2009 16 4 470 475
62. Al-Mutairi S., Al-Awadhi A., Raghupathy R., Al-Khawari H., Sada P., Al-Herz A., Rawoot P., Lupus patients with pulmonary involvement have a pro-inflammatory cytokines profile Rheumatology International 2007 27 7 621 630
63. Santiago M.-L., Fossati L., Jacquet C., Mller W., Izui S., Reininger L., Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome Journal of Experimental Medicine 1997 185 1 65 70
64. Muller W., Kuhn R., Rajewsky K., Major histocompatibility complex class II hyperexpression on B cells in interleukin 4-transgenic mice does not lead to B cell proliferation and hypergammaglobulinemia European Journal of Immunology 1991 21 4 921 925
65. Leal L. M. C. C., Moss D. W., Kuhn R., Muller W., Liew F. Y., Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection European Journal of Immunology 1993 23 2 566 569
66. Sher A., Coffman R. L., Regulation of immunity to parasites by T cells and T cell-derived cytokines Annual Review of Immunology 1992 10 385 409
67. Rcken M., Racke M., Shevach E. M., IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease Immunology Today 1996 17 5 225 231
68. Hayashi T., Hasegawa K., Sasaki Y., Mori T., Adachi C., Maeda K., Systemic administration of interleukin-4 expressing plasmid DNA delays the development of glomerulonephritis and prolongs survival in lupus-prone female NZB NZW F 1 mice Nephrology Dialysis Transplantation 2007 22 11 3131 3138
69. Nitta Y., Tashiro F., Tokui M., Shimada A., Takei I., Tabayashi K., Miyazaki J.-I., Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice Human Gene Therapy 1998 9 12 1701 1707
70. Lee M., Jae J. K., Han S.-O., Ko K. S., Ki S. W., Prevention of autoimmune insulitis by delivery of interleukin-4 plasmid using a soluble and biodegradable polymeric carrier Pharmaceutical Research 2002 19 3 246 249
71. Piccirillo C. A., Prud'homme G. J., Immune modulation by plasmid DNA-mediated cytokine gene transfer Current Pharmaceutical Design 2003 9 1 83 94
72. Klinman D. M., Yi A.-K., Beaucage S. L., Conover J., Krieg A. M., CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon Proceedings of the National Academy of Sciences of the United States of America 1996 93 7 2879 2883
73. Pisetsky D. S., Immune activation by bacterial DNA: a new genetic code Immunity 1996 5 4 303 310
74. Mazda O., Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors Current Gene Therapy 2002 2 3 379 392
75. Casali P., Notkins A. L., CD5 + B lymphocytes, polyreactive antibodies and the human B-cell repertoire Immunology Today 1989 10 11 364 368
76. Wen X., Zhang D., Kikuchi Y., Jiang Y., Nakamura K., Xiu Y., Tsurui H., Takahashi K., Abe M., Ohtsuji M., Nishimura H., Takatsu K., Shirai T., Hirose S., Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus European Journal of Immunology 2004 34 10 2740 2749
77. Hagiwara E., Okubo T., Aoki I., Ohno S., Tsuji T., Ihata A., Ueda A., Shirai A., Okuda K., Miyazaki J.-I., Ishigatsubo Y., IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice Cytokine 2000 12 7 1035 1041
78. Mageed R. A., Prud'homme G. J., Immunopathology and the gene therapy of lupus Gene Therapy 2003 10 10 861 874
79. Ozmen L., Roman D., Fountoulakis M., Schmid G., Ryffel B., Garotta G., Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon- receptor inhibits the onset of glomerulonephritis European Journal of Immunology 1995 25 1 6 12
80. Lawson B. R., Prud'homme G. J., Chang Y., Gardner H. A., Kuan J., Kono D. H., Theofilopoulos A. N., Treatment of murine lupus with cDNA encoding IFN- R/Fc Journal of Clinical Investigation 2000 106 2 207 215
81. Prud'homme G. J., Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors Journal of Gene Medicine 2000 2 4 222 232
82. Boss P., Neumann D., Del Giudice E., Ciaramella A., Gloaguen I., Fantuzzi G., Dinarello C. A., Di Carlo E., Musiani P., Meroni P. L., Caselli G., Ruggiero P., Boraschi D., IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease Proceedings of the National Academy of Sciences of the United States of America 2003 100 2 14181 14186
83. Esfandiari E., McInnes I. B., Lindop G., Huang F.-P., Field M., Komai-Koma M., Wei X.-Q., Liew F. Y., A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease Journal of Immunology 2001 167 9 5338 5347
84. Schwarting A., Tesch G., Kinoshita K., Maron R., Weiner H. L., Kelley V. R., IL-12 drives IFN- -dependent autoimmune kidney disease in MRL-Fas(lpr) mice Journal of Immunology 1999 163 12 6884 6891
85. Park M. C., Park Y. B., Lee S. K., Elevated interleukin-18 levels correlated with disease activity in systemic lupus erythematosus Clinical Rheumatology 2004 23 3 225 229
86. Wozniacka A., Lesiak A., Narbutt J., McCauliffe D. P., Sysa-Jedrzejowska A., Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients Lupus 2006 15 5 268 275
87. Neumann D., Tschernig T., Popa D., Schmiedl A., de Lema G. P., Resch K., Martin M. U., Injection of IL-12- and IL-18-encoding plasmids ameliorates the autoimmune pathology of MRL/Mp-Tnfrsf6lpr mice: synergistic effect on autoimmune symptoms International Immunology 2006 18 12 1779 1787
88. Raz E., Dudler J., Lotz M., Baird S. M., Berry C. C., Eisenberg R. A., Carson D. A., Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery Lupus 1995 4 4 286 292
89. Huggins M. L., Huang F.-P., Xu D., Lindop G., Stott D. I., Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF- 1 gene therapy using attenuated Salmonella typhimurium as gene carrier Lupus 1999 8 1 29 38
90. Gutierrez-Ramos J. C., Andreu J. L., Revilla Y., Vinuela E., Martinez C., Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus Nature 1990 346 6281 271 274
91. Wang X., Huang W., Schiffer L. E., Mihara M., Akkerman A., Hiromatsu K., Davidson A., Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus Arthritis and Rheumatism 2003 48 2 495 506 (Pubitemid 36278019)
92. Takiguchi M., Murakami M., Nakagawa I., Saito I., Hashimoto A., Uede T., CTLA4IgG gene delivery prevents autoantibody production and lupus nephritis in MRL/lpr mice Life Sciences 2000 66 11 991 1001
93. Mihara M., Tan I., Chuzhin Y., Reddy B., Budhai L., Holzer A., Gu Y., Davidson A., CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus Journal of Clinical Investigation 2000 106 1 91 101
94. Ye X., Zhu T., Bastacky S., McHale T., Li J., Xiao X., Prevention and reversal of lupus in NZB/NZW mice by costimulatory blockade with adeno-associated virus-mediated gene transfer Arthritis and Rheumatism 2005 52 12 3975 3986
95. Ding H., Wu X., Wu J., Yagita H., He Y., Zhang J., Ren J., Gao W., Delivering PD-1 inhibitory signal concomitant with blocking ICOS co-stimulation suppresses lupus-like syndrome in autoimmune BXSB mice Clinical Immunology 2006 118 2-3 258 267
96. Nishimura H., Honjo T., PD-1: an inhibitory immunoreceptor involved in peripheral tolerance Trends in Immunology 2001 22 5 265 268
97. Freeman G. J., Long A. J., Iwai Y., Bourque K., Chernova T., Nishimura H., Fitz L. J., Malenkovich N., Okazaki T., Byrne M. C., Horton H. F., Fouser L., Carter L., Ling V., Bowman M. R., Carreno B. M., Collins M., Wood C. R., Honjo T., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation Journal of Experimental Medicine 2000 192 7 1027 1034
98. Carter L. L., Fouser L. A., Jussif J., Fitz L., Deng B., Wood C. R., Collins M., Honjo T., Freeman G. J., Carreno B. M., PD-1:PD-L inhibitory pathway affects both CD4 + and CD8 + T cells and is overcome by IL-2 European Journal of Immunology 2002 32 3 634 643
99. Zhong X., Bai C., Gao W., Strom T. B., Rothstein T. L., Suppression of expression and function of negative immune regulator PD-1 by certain pattern recognition and cytokine receptor signals associated with immune system danger International Immunology 2004 16 8 1181 1188
100. Dong C., Juedes A. E., Temann U.-A., Shresta S., Allison J. P., Ruddle N. H., Flavell R. A., ICOS co-stimulatory receptor is essential for T-cell activation and function Nature 2001 409 6816 97 101
101. McAdam A. J., Greenwald R. J., Levin M. A., Chernova T., Malenkovich N., Ling V., Freeman G. J., Sharpe A. H., Icos is critical for CD40-mediated antibody class switching Nature 2001 409 6816 102 105
102. Tafuri A., Shahinian A., Bladt F., Yoshinaga S. K., Jordana M., Wakeham A., Boucher L.-M., Bouchard D., Chan V. S. F., Duncan G., Odermatt B., Ho A., Itie A., Horan T., Whoriskey J. S., Pawson T., Penninger J. M., Ohashi P. S., Mak T. W., ICOS is essential for effective T-helper-cell responses Nature 2001 409 6816 105 109
103. Liu W., Szalai A., Zhao L., Liu D., Martin F., Kimberly R. P., Zhou T., Carter R. H., Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI Arthritis and Rheumatism 2004 50 6 1884 1896
104. Haviv Y. S., Takayama K., Nagi P. A., Tousson A., Cook W., Wang M., Lam J. T., Naito S., Lei X., Carey D. E., Curiel D. T., Modulation of renal glomerular disease using remote delivery of adenoviral-encoded soluble type II TGF- receptor fusion molecule Journal of Gene Medicine 2003 5 10 839 851
105. Pascual V., Farkas L., Banchereau J., Systemic lupus erythematosus: all roads lead to type I interferons Current Opinion in Immunology 2006 18 6 676 682 (Pubitemid 44635182)
106. Horwitz D. A., Regulatory T cells in systemic lupus erythematosus: past, present and future Arthritis Research and Therapy 2008 10 6, article 227
107. Pasare C., Medzhitov R., Toll pathway-dependent blockade of CD4 + CD25 + T cell-mediated suppression by dendritic cells Science 2003 299 5609 1033 1036
108. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.-J., Pulendran B., Palucka K., Immunobiology of dendritic cells Annual Review of Immunology 2000 18 767 811
109. Liu Y.-J., IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors Annual Review of Immunology 2005 23 275 306
110. Mohty M., Vialle-Castellano A., Nunes J. A., Isnardon D., Olive D., Gaugler B., IFN- skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities Journal of Immunology 2003 171 7 3385 3393
111. Boruchov A. M., Heller G., Veri M.-C., Bonvini E., Ravetch J. V., Young J. W., Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions Journal of Clinical Investigation 2005 115 10 2914 2923
112. Dhodapkar K. M., Kaufman J. L., Ehlers M., Banerjee D. K., Bonvini E., Koenig S., Steinman R. M., Ravetch J. V., Dhodapkar M. V., Selective blockade of inhibitory Fc receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells Proceedings of the National Academy of Sciences of the United States of America 2005 102 8 2910 2915
113. Grouard G., Rissoan M.-C., Filgueira L., Durand I., Banchereau J., Liu Y.-J., The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand Journal of Experimental Medicine 1997 185 6 1101 1111
114. Vollmer J., Tluk S., Schmitz C., Hamm S., Jurk M., Forsbach A., Akira S., Kelly K. M., Reeves W. H., Bauer S., Krieg A. M., Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8 Journal of Experimental Medicine 2005 202 11 1575 1585
115. Gill M. A., Blanco P., Arce E., Pascual V., Banchereau J., Palucka A. K., Blood dendritic cells and DC-poietins in systemic lupus erythematosus Human Immunology 2002 63 12 1172 1180
116. Jacob C. O., McDevitt H. O., Tumour necrosis factor- in murine autoimmune 'lupus' nephritis Nature 1988 331 6154 356 358
117. Toubi E., The role of CD4 + CD25 + T regulatory cells in autoimmune diseases Clinical Reviews in Allergy and Immunology 2008 34 3 338 344
118. Hayashi T., Aucoin L., Prideux T., Environmental factors and concepts in the induction of type 1 diabetes Hand book of Type 1 Diabetes Mellitus: Etiology, Diagnosis and Treatment 2010 chapter 1 1 45
119. Hayashi T., Hasegawa K., Adachi C., Elimination of CD4 + CD25 + T cell accelerates the development of glomerulonephritis during the preactive phase in autoimmune-prone female NZB NZWF 1 mice International Journal of Experimental Pathology 2005 86 5 289 296
120. Hayashi T., Adachi C., Hasegawa K., Systemic treatment of anti-CD4 + CD25 + T cell monoclonal antibody exacerbates sialoadenitis in submandibular glands during the early life in lupus-prone female NZB NZWF 1 mice Journal of Oral Pathology and Medicine 2009 38 2 234 240
121. Scalapino K. J., Tang Q., Bluestone J. A., Bonyhadi M. L., Daikh D. I., Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells Journal of Immunology 2006 177 3 1451 1459
122. Lan R. Y., Ansari A. A., Lian Z.-X., Gershwin M. E., Regulatory T cells: development, function and role in autoimmunity Autoimmunity Reviews 2005 4 6 351 363
123. Baecher-Allan C., Brown J. A., Freeman G. J., Hafler D. A., CD4 + CD25 high regulatory cells in human peripheral blood Journal of Immunology 2001 167 3 1245 1253
124. Zheng S. G., Wang J. H., Koss M. N., Quismorio F. Jr., Gray J. D., Horwitz D. A., CD4 + and CD8 + regulatory T cells generated ex vivo with IL-2 and TGF- suppress a stimulatory graft-versus-host disease with a lupus-like syndrome Journal of Immunology 2004 172 3 1531 1539
125. Koenen H. J. P. M., Smeets R. L., Vink P. M., van Rijssen E., Boots A. M. H., Joosten I., Human CD25 high Foxp3 pos regulatory T cells differentiate into IL-17 producing cells Blood 2008 112 6 2340 2352
126. Xu L., Kitani A., Fuss I., Strober W., Cutting edge: regulatory T cells induce CD4 + CD25 - Foxp3 - T cells or are self-induced to become Th17 cells in the absence of exogenous TGF- Journal of Immunology 2007 178 11 6725 6729
127. Tang Q., Adams J. Y., Tooley A. J., Bi M., Fife B. T., Serra P., Santamaria P., Locksley R. M., Krummel M. F., Bluestone J. A., Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice Nature Immunology 2006 7 1 83 92
128. Tadokoro C. E., Shakhar G., Shen S., Ding Y., Lino A. C., Maraver A., Lafaille J. J., Dustin M. L., Regulatory T cells inhibit stable contacts between CD4 + T cells and dendritic cells in vivo Journal of Experimental Medicine 2006 203 3 505 511
129. Terme M., Chaput N., Combadiere B., Averil M., Ohteki T., Zitvogel L., Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4 + self-reactive T cells Journal of Immunology 2008 180 7 4679 4686
130. Zhao D.-M., Thornton A. M., DiPaolo R. J., Shevach E. M., Activated CD4 + CD25 + T cells selectively kill B lymphocytes Blood 2006 107 10 3925 3932
131. Giroux M., Yurchenko E., St-Pierre J., Piccirillo C. A., Perreault C., T regulatory cells control numbers of NK cells and CD8 + immature dendritic cells in the lymph node paracortex Journal of Immunology 2007 179 7 4492 4502
132. Min W.-P., Zhou D., Ichim T. E., Strejan G. H., Xia X., Yang J., Huang X., Garcia B., White D., Dutartre P., Jevnikar A. M., Zhong R., Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance Journal of Immunology 2003 170 3 1304 1312
133. Cai Y., Rodriguez S., Rameswaran R., Draghia-Akli R., Juba R. J. Jr., Hebel H., Production of pharmaceutical-grade plasmids at high concentration and high supercoiled percentage Vaccine 2010 28 8 2046 2052
134. Voss C., Production of plasmid DNA for pharmaceutical use Biotechnology Annual Review 2007 13 201 222
135. Przybylowski M., Bartido S., Borquez-Ojeda O., Sadelain M., Rivire I., Production of clinical-grade plasmid DNA for human Phase I clinical trials and large animal clinical studies Vaccine 2007 25 27 5013 5024
136. Tripathy S. K., Svensson E. C., Black H. B., Goldwasser E., Margalith M., Hobart P. M., Leiden J. M., Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector Proceedings of the National Academy of Sciences of the United States of America 1996 93 20 10876 10880
137. Wolff J. A., Ludtke J. J., Acsadi G., Williams P., Jani A., Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle Human Molecular Genetics 1992 1 6 363 369
138. Wolff J. A., Malone R. W., Williams P., Direct gene transfer into mouse muscle in vivo Science 1990 247 4949 1465 1468
139. Evans C. H., Robbins P. D., Ghivizzani S. C., Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis Human Gene Therapy 1996 7 10 1261 1280
140. Evans C. H., Ghivizzani S. C., Robbins P. D., Gene therapy of the rheumatic diseases: 1998 to 2008 Arthritis Research and Therapy 2009 11 1, article 209
141. Wehling P., Reinecke J., Baltzer A. W. A., Granrath M., Schulitz K. P., Schultz C., Krauspe R., Whiteside T. W., Elder E., Ghivizzani S. C., Robbins P. D., Evans C. H., Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritis Human Gene Therapy 2009 20 2 97 101
142. Davis H. L., Demeneix B. A., Quantin B., Coulombe J., Whalen R. G., Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle Human Gene Therapy 1993 4 6 733 740
143. Kyttaris V. C., Sfikakis P. P., Juang Y.-T., Tsokos G. C., Gene therapy in systemic lupus erythematosus Current Gene Therapy 2005 5 6 677 684
144. Hayashi T., Morimoto M., Iwata H., Onodera T., Possible involvement of IL-12 in reovirus type-2-induced diabetes in newborn DBA/1 mice Scandinavian Journal of Immunology 2001 53 6 572 578
145. Liu K., Mohan C., What do mouse models teach us about human SLE? Clinical Immunology 2006 119 2 123 130
146. Pisitkun P., Deane J. A., Difilippantonio M. J., Tarasenko T., Satterthwaite A. B., Bolland S., Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication Science 2006 312 5780 1669 1672
147. Subramanian S., Tus K., Li Q.-Z., Wang A., Tian X.-H., Zhou J., Liang C., Bartov G., McDaniel L. D., Zhou X. J., Schultz R. A., Wakeland E. K., A Tlr7 translocation accelerates systemic autoimmunity in murine lupus Proceedings of the National Academy of Sciences of the United States of America 2006 103 26 9970 9975